NCT06129604View on ClinicalTrials.gov

Pilot Window of Opportunity Trial (POET)

PHASE2RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 3, 2024

Primary Completion Date

December 30, 2025

Study Completion Date

September 30, 2026

Conditions
Colorectal Carcinoma (CRC)Endometrial Carcinoma (EC)
Interventions
DRUG

TPST-1495

Eligible subjects will receive study treatment of 50mg TPST-1495 taken orally, once a day for 7 days prior and discontinued 3 days prior to scheduled surgery.

Trial Locations (1)

73117

RECRUITING

OU Health Stephenson Cancer Center, Oklahoma City

All Listed Sponsors
lead

University of Oklahoma

OTHER